Literature DB >> 15575898

Severe preservation injury induces Il-6/STAT3 activation with lack of cell cycle progression after partial liver graft transplantation.

Fotini Debonera1, Guodong Wang, Jinfu Xie, Xingye Que, Andrew Gelman, Cynthia Leclair, Dong Xin, Abraham Shaked, Kim M Olthoff.   

Abstract

Partial liver graft transplantation is a surgical advance developed to overcome severe donor shortage. Survival of these grafts involves recovery from cold ischemia and reperfusion (CIR) injury, immediate regeneration and maintenance of function. Here we examined the outcome of partial liver grafts in comparison to whole grafts following CIR injury. Lewis rats subjected to orthotopic liver transplantation (OLT) with whole grafts preserved in Viaspan were compared to rats receiving 50% and 30% grafts. Outcome was analyzed by survival and regeneration. Transplantation was associated with 100% survival for all grafts, whereas 16 h preservation resulted in 100%, 20% and 0% survival in animals receiving whole, 50% and 30% grafts, respectively. CIR induced increased IL-6 levels in 50% and 30% grafts, and activation of STAT3. Cell cycle progression (cyclin D1) and regeneration (BrdU) was initiated in all livers preserved for 1 or 8 h, but not in partial grafts preserved for 16 h. In conclusion, partial grafts recover from CIR injury through similar molecular pathways to whole grafts. Partial grafts with severe injury fail to achieve cellular proliferation despite the early initiating signals. This failure could be attributed to the impaired ability of the parenchyma to respond to initiating signals for regeneration.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15575898     DOI: 10.1111/j.1600-6143.2004.00626.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  6 in total

1.  Hydrogen sulfide augments survival signals in warm ischemia and reperfusion of the mouse liver.

Authors:  Shingo Shimada; Moto Fukai; Kenji Wakayama; Takahisa Ishikawa; Nozomi Kobayashi; Taichi Kimura; Kenichiro Yamashita; Toshiya Kamiyama; Tsuyoshi Shimamura; Akinobu Taketomi; Satoru Todo
Journal:  Surg Today       Date:  2014-11-02       Impact factor: 2.549

2.  Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium.

Authors:  Kim M Olthoff; Robert M Merion; Rafik M Ghobrial; Michael M Abecassis; Jeffrey H Fair; Robert A Fisher; Chris E Freise; Igal Kam; Timothy L Pruett; James E Everhart; Tempie E Hulbert-Shearon; Brenda W Gillespie; Jean C Emond
Journal:  Ann Surg       Date:  2005-09       Impact factor: 12.969

3.  Activation of innate immunity (NK/IFN-gamma) in rat allogeneic liver transplantation: contribution to liver injury and suppression of hepatocyte proliferation.

Authors:  Kezhen Shen; Shu-Sen Zheng; Ogyi Park; Hua Wang; Zhaoli Sun; Bin Gao
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-02-21       Impact factor: 4.052

4.  Unique early gene expression patterns in human adult-to-adult living donor liver grafts compared to deceased donor grafts.

Authors:  J de Jonge; S Kurian; A Shaked; K R Reddy; W Hancock; D R Salomon; K M Olthoff
Journal:  Am J Transplant       Date:  2009-04       Impact factor: 8.086

5.  Hypothermia predicts hepatic failure after extensive hepatectomy in mice.

Authors:  Norifumi Ohashi; Tomohide Hori; Shinji Uemoto; Sura Jermanus; Feng Chen; Akimasa Nakao; Justin H Nguyen
Journal:  World J Hepatol       Date:  2013-04-27

6.  Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation.

Authors:  A Shaked; R M Ghobrial; R M Merion; T H Shearon; J C Emond; J H Fair; R A Fisher; L M Kulik; T L Pruett; N A Terrault
Journal:  Am J Transplant       Date:  2008-12-15       Impact factor: 8.086

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.